ATC Index
Explore Levocarnitine, an essential amino acid derivative used to treat primary and secondary carnitine deficiencies, improving energy metabolism and muscle function.
Browse our catalog for available pharmaceutical products and competitive pricing.
Levocarnitine, also known as L-carnitine, is a naturally occurring quaternary ammonium compound that plays a vital role in energy metabolism. It is derived from the amino acids lysine and methionine and is essential for the transport of long-chain fatty acids into the mitochondria, where they undergo beta-oxidation to produce energy. While the human body can synthesize Levocarnitine, certain genetic conditions, medical treatments, or diseases can lead to a deficiency, necessitating supplementation. It is classified as a metabolic agent and nutritional supplement with the ATC code A16.
The discovery of carnitine dates back to 1905 when it was isolated from muscle extracts. Its physiological importance, particularly its role in fatty acid metabolism, was elucidated in the mid-20th century. Clinical applications of Levocarnitine began to emerge as its role in various metabolic disorders became clearer. Initially used to treat specific inborn errors of metabolism, its utility expanded to secondary carnitine deficiencies, particularly those associated with hemodialysis and certain drug toxicities. The understanding of its mechanism has continued to evolve, solidifying its place in modern medicine.
As a pharmaceutical compound, Levocarnitine is available in various forms, including oral solutions, tablets, and intravenous injections, allowing for flexible administration based on patient needs and the severity of the deficiency. It is not considered a vitamin but rather a vitamin-like compound due to its essential metabolic functions. The careful management of Levocarnitine levels is crucial for individuals with impaired fatty acid oxidation, as inadequate amounts can lead to severe metabolic dysfunction, muscle weakness, cardiomyopathy, and other systemic issues.
The primary mechanism of action of Levocarnitine revolves around its critical role in the carnitine shuttle system, which is responsible for transporting long-chain fatty acids from the cytosol into the mitochondrial matrix. This transport is a rate-limiting step for beta-oxidation, the metabolic pathway that breaks down fatty acids to generate acetyl-CoA, which then enters the Krebs cycle to produce ATP. Levocarnitine facilitates this process by forming long-chain acylcarnitines, which can cross the inner mitochondrial membrane via the carnitine-acylcarnitine translocase enzyme. Without sufficient Levocarnitine, long-chain fatty acids accumulate in the cytosol, leading to energy deficits and the potential for cellular damage from toxic fatty acid intermediates.
Beyond its direct role in fatty acid transport, Levocarnitine also helps in the removal of excess short- and medium-chain acyl-CoAs that can accumulate during metabolic stress or in certain inborn errors of metabolism. By converting these toxic acyl-CoAs into their corresponding acylcarnitines, Levocarnitine facilitates their excretion from the body, thereby preventing their inhibitory effects on various enzyme systems and reducing cellular toxicity. This dual function of both facilitating energy production and detoxifying metabolic byproducts underscores the broad physiological importance of adequate Levocarnitine levels for overall cellular health and function.
Levocarnitine is widely used in medical practice to address various conditions characterized by carnitine deficiency or impaired fatty acid metabolism. Its therapeutic efficacy stems from its ability to restore normal carnitine levels, thereby improving energy production and reducing the accumulation of toxic metabolic intermediates. The indications for Levocarnitine supplementation range from genetic disorders to acquired deficiencies resulting from medical treatments or chronic diseases.
The dosage and administration of Levocarnitine are highly individualized, depending on the patient's age, weight, the specific indication, the severity of the carnitine deficiency, and the route of administration (oral or intravenous). Treatment typically begins with a lower dose, which may be gradually increased based on clinical response and monitoring of plasma carnitine levels. It is crucial to adhere strictly to the prescribing physician's instructions.
| Indication | Typical Dose | Frequency | Route |
|---|---|---|---|
| Primary Carnitine Deficiency | 50-100 mg/kg/day | Divided doses (2-3 times daily) | Oral |
| Secondary Carnitine Deficiency (Hemodialysis) | 10-20 mg/kg | After each dialysis session | Intravenous |
| Valproate Toxicity | 100 mg/kg/day (max 3g/day) | Divided doses (3-4 times daily) | Oral or Intravenous |
| Inborn Errors of Metabolism | 50-100 mg/kg/day | Divided doses (2-4 times daily) | Oral or Intravenous |
Important: Always follow your prescriber instructions. Dosages vary by weight, age, and condition. Self-medication with Levocarnitine is not recommended, and therapy should always be managed by a qualified healthcare professional.
While generally well-tolerated, Levocarnitine can cause side effects, particularly at higher doses or in sensitive individuals. Most adverse effects are gastrointestinal in nature and mild to moderate in severity.
Levocarnitine generally has a favorable interaction profile, but certain medications can influence its effects or be affected by its presence. It's crucial for patients to inform their healthcare provider about all medications, supplements, and herbal products they are taking to prevent potential interactions.
Medical Disclaimer: This information is for educational purposes only. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment.
Yes, Levocarnitine is generally considered safe for long-term use, especially in patients with chronic conditions requiring continuous supplementation for primary or secondary carnitine deficiencies. However, long-term therapy should always be under the supervision of a healthcare professional who will monitor its effectiveness and any potential side effects. Regular follow-up appointments and blood tests to check carnitine levels may be necessary.
Yes, oral Levocarnitine can typically be taken with or without food. However, taking it with meals is often recommended to minimize gastrointestinal side effects such as nausea, vomiting, or abdominal discomfort, which can sometimes occur. Following the specific instructions provided by your doctor or pharmacist regarding mealtime administration is always best.
If you miss a dose of Levocarnitine, take it as soon as you remember, unless it is almost time for your next scheduled dose. In that case, skip the missed dose and continue with your regular dosing schedule. Do not double the dose to catch up. Consistent administration is important for maintaining stable carnitine levels, so try to take your medication at the same time each day.
Levocarnitine is a prescription medication in many countries and should only be obtained through licensed medical channels. This includes pharmacies, hospitals, or specialized medical suppliers, typically with a valid prescription from a qualified healthcare provider. It is crucial to avoid purchasing Levocarnitine from unregulated online sources or unauthorized vendors, as product quality, purity, and authenticity cannot be guaranteed, potentially posing health risks.
Chat on WhatsApp